14 | | - | Section 1. K.S.A. 21-5701 is hereby amended to read as follows: |
---|
15 | | - | 21-5701. As used in K.S.A. 21-5701 through 21-5717, and amendments |
---|
16 | | - | thereto: |
---|
17 | | - | (a) "Controlled substance" means any drug, substance or |
---|
18 | | - | immediate precursor included in any of the schedules designated in |
---|
19 | | - | K.S.A. 65-4105, 65-4107, 65-4109, 65-4111 and 65-4113, and |
---|
20 | | - | amendments thereto. |
---|
21 | | - | (b) (1) "Controlled substance analog" means a substance that is |
---|
22 | | - | intended for human consumption, and at least one of the following: |
---|
23 | | - | (A) The chemical structure of the substance is substantially similar |
---|
24 | | - | to the chemical structure of a controlled substance listed in or added to |
---|
25 | | - | the schedules designated in K.S.A. 65-4105 or 65-4107, and |
---|
26 | | - | amendments thereto; |
---|
27 | | - | (B) the substance has a stimulant, depressant or hallucinogenic |
---|
28 | | - | effect on the central nervous system substantially similar to the |
---|
29 | | - | stimulant, depressant or hallucinogenic effect on the central nervous |
---|
30 | | - | system of a controlled substance included in the schedules designated |
---|
31 | | - | in K.S.A. 65-4105 or 65-4107, and amendments thereto; or |
---|
32 | | - | (C) with respect to a particular individual, such individual |
---|
33 | | - | represents or intends the substance to have a stimulant, depressant or |
---|
34 | | - | hallucinogenic effect on the central nervous system substantially |
---|
35 | | - | similar to the stimulant, depressant or hallucinogenic effect on the |
---|
36 | | - | central nervous system of a controlled substance included in the |
---|
37 | | - | schedules designated in K.S.A. 65-4105 or 65-4107, and amendments |
---|
38 | | - | thereto. |
---|
39 | | - | (2) "Controlled substance analog" does not include: |
---|
40 | | - | (A) A controlled substance; |
---|
41 | | - | (B) a substance for which there is an approved new drug |
---|
42 | | - | application; or |
---|
43 | | - | (C) a substance with respect to which an exemption is in effect for |
---|
44 | | - | investigational use by a particular person under section 505 of the |
---|
45 | | - | federal food, drug, and cosmetic act, 21 U.S.C. § 355, to the extent |
---|
46 | | - | conduct with respect to the substance is permitted by the exemption. |
---|
47 | | - | (c) "Cultivate" means the planting or promotion of growth of five |
---|
48 | | - | or more plants that contain or can produce controlled substances. |
---|
49 | | - | (d) "Distribute" means the actual, constructive or attempted |
---|
50 | | - | transfer from one person to another of some item whether or not there |
---|
51 | | - | is an agency relationship. "Distribute" includes, but is not limited to, |
---|
52 | | - | sale, offer for sale or any act that causes some item to be transferred |
---|
53 | | - | from one person to another. "Distribute" does not include acts of |
---|
54 | | - | administering, dispensing or prescribing a controlled substance as |
---|
55 | | - | authorized by the pharmacy act of the state of Kansas, the uniform |
---|
56 | | - | controlled substances act or otherwise authorized by law. |
---|
57 | | - | (e) (1) "Drug" means: |
---|
58 | | - | (A) Substances recognized as drugs in the official United States |
---|
59 | | - | pharmacopeia, official homeopathic pharmacopoeia of the United |
---|
60 | | - | States or official national formulary or any supplement to any of them; |
---|
61 | | - | (B) substances intended for use in the diagnosis, cure, mitigation, |
---|
62 | | - | treatment or prevention of disease in humans or animals; |
---|
63 | | - | (C) substances, other than food, intended to affect the structure or |
---|
64 | | - | any function of the body of humans or animals; and |
---|
65 | | - | (D) substances intended for use as a component of any article |
---|
66 | | - | specified in subparagraph (A), (B) or (C). HOUSE BILL No. 2547—page 2 |
---|
67 | | - | (2) "Drug" does not include devices or their components, parts or |
---|
68 | | - | accessories. |
---|
69 | | - | (f) (1) "Drug paraphernalia" means all equipment and materials of |
---|
70 | | - | any kind that are used, or primarily intended or designed for use in |
---|
71 | | - | planting, propagating, cultivating, growing, harvesting, manufacturing, |
---|
72 | | - | compounding, converting, producing, processing, preparing, testing, |
---|
73 | | - | analyzing, packaging, repackaging, storing, containing, concealing, |
---|
74 | | - | injecting, ingesting, inhaling or otherwise introducing into the human |
---|
75 | | - | body a controlled substance and in violation of this act. |
---|
76 | | - | (2) "Drug paraphernalia" includes, but is not limited to: |
---|
77 | | - | (A) Kits used or intended for use in planting, propagating, |
---|
78 | | - | cultivating, growing or harvesting any species of plant that is a |
---|
79 | | - | controlled substance or from which a controlled substance can be |
---|
80 | | - | derived; |
---|
81 | | - | (B) kits used or intended for use in manufacturing, compounding, |
---|
82 | | - | converting, producing, processing or preparing controlled substances; |
---|
83 | | - | (C) isomerization devices used or intended for use in increasing |
---|
84 | | - | the potency of any species of plant that is a controlled substance; |
---|
85 | | - | (D) testing equipment used or intended for use in identifying or in |
---|
86 | | - | analyzing the strength, effectiveness or purity of controlled substances; |
---|
87 | | - | (E) scales and balances used or intended for use in weighing or |
---|
88 | | - | measuring controlled substances; |
---|
89 | | - | (F) diluents and adulterants, including, but not limited to, quinine |
---|
90 | | - | hydrochloride, mannitol, mannite, dextrose and lactose that are used or |
---|
91 | | - | intended for use in cutting controlled substances; |
---|
92 | | - | (G) separation gins and sifters used or intended for use in |
---|
93 | | - | removing twigs and seeds from or otherwise cleaning or refining |
---|
94 | | - | marijuana; |
---|
95 | | - | (H) blenders, bowls, containers, spoons and mixing devices used |
---|
96 | | - | or intended for use in compounding controlled substances; |
---|
97 | | - | (I) capsules, balloons, envelopes, bags and other containers used |
---|
98 | | - | or intended for use in packaging small quantities of controlled |
---|
99 | | - | substances; |
---|
100 | | - | (J) containers and other objects used or intended for use in storing |
---|
101 | | - | or concealing controlled substances; |
---|
102 | | - | (K) hypodermic syringes, needles and other objects used or |
---|
103 | | - | intended for use in parenterally injecting controlled substances into the |
---|
104 | | - | human body; |
---|
105 | | - | (L) objects used or primarily intended or designed for use in |
---|
106 | | - | ingesting, inhaling or otherwise introducing marijuana, cocaine, |
---|
107 | | - | hashish, hashish oil, phencyclidine (PCP), methamphetamine or |
---|
108 | | - | amphetamine into the human body, such as: |
---|
109 | | - | (i) Metal, wooden, acrylic, glass, stone, plastic or ceramic pipes |
---|
110 | | - | with or without screens, permanent screens, hashish heads or punctured |
---|
111 | | - | metal bowls; |
---|
112 | | - | (ii) water pipes, bongs or smoking pipes designed to draw smoke |
---|
113 | | - | through water or another cooling device; |
---|
114 | | - | (iii) carburetion pipes, glass or other heat-resistant tubes or any |
---|
115 | | - | other device used, intended to be used or designed to be used to cause |
---|
116 | | - | vaporization of a controlled substance for inhalation; |
---|
117 | | - | (iv) smoking and carburetion masks; |
---|
118 | | - | (v) roach clips, objects used to hold burning material, such as a |
---|
119 | | - | marijuana cigarette, that has become too small or too short to be held in |
---|
120 | | - | the hand; |
---|
121 | | - | (vi) miniature cocaine spoons and cocaine vials; |
---|
122 | | - | (vii) chamber smoking pipes; |
---|
123 | | - | (viii) carburetor smoking pipes; |
---|
124 | | - | (ix) electric smoking pipes; |
---|
125 | | - | (x) air-driven smoking pipes; HOUSE BILL No. 2547—page 3 |
---|
126 | | - | (xi) chillums; |
---|
127 | | - | (xii) bongs; |
---|
128 | | - | (xiii) ice pipes or chillers; |
---|
129 | | - | (xiv) any smoking pipe manufactured to disguise its intended |
---|
130 | | - | purpose; |
---|
131 | | - | (xv) wired cigarette papers; or |
---|
132 | | - | (xvi) cocaine freebase kits. |
---|
133 | | - | (3) "Drug paraphernalia" does not include: |
---|
134 | | - | (A) Any products, chemicals or materials described in K.S.A. 21- |
---|
135 | | - | 5709(a), and amendments thereto; or |
---|
136 | | - | (B) any materials used or intended for use to test a substance for |
---|
137 | | - | the presence of fentanyl, a fentanyl analog, ketamine or gamma |
---|
138 | | - | hydroxybutyric acid. |
---|
139 | | - | (g) "Fentanyl-related controlled substance" means any substance |
---|
140 | | - | designated in K.S.A. 65-4105(b)(1), (b)(2), (b)(4), (b)(10), (b)(11), (b) |
---|
141 | | - | (12), (b)(14), (b)(15), (b)(16), (b)(17), (b)(20), (b)(21), (b)(22), (b)(23), |
---|
142 | | - | (b)(24), (b)(26), (b)(27), (b)(28), (b)(35), (b)(37), (b)(41), (b)(42), (b) |
---|
143 | | - | (43), (b)(44), (b)(45), (b)(46), (b)(47), (b)(49) (b)(48), (b)(50), (b)(54), |
---|
144 | | - | (b)(55), (b)(56), (b)(57), (b)(58), (b)(59), (b)(60), (b)(61), (b)(62) (b) |
---|
145 | | - | (68), (b)(70), (b)(71), (b)(72), (b)(73), (b)(74), (b)(75), (b)(76), (b)(77), |
---|
146 | | - | (b)(78), (b)(79), (b)(80), (b)(81), (b)(82), (b)(83), (b)(84), (b)(85), (b) |
---|
147 | | - | (91), (b)(97), (b)(98), (b)(99), (b)(103), (b)(104), (g)(1) or (g)(2) or 65- |
---|
148 | | - | 4107(c)(1), (c)(6), (c)(9), (c)(26), (c)(28), (c)(30), (f)(3)(A) or (f)(3) |
---|
149 | | - | (B), and amendments thereto, or any analog thereof. |
---|
150 | | - | (h) "Immediate precursor" means a substance that the state board |
---|
151 | | - | of pharmacy has found to be and by rules and regulations designates as |
---|
152 | | - | being the principal compound commonly used or produced primarily |
---|
153 | | - | for use and that is an immediate chemical intermediary used or likely to |
---|
154 | | - | be used in the manufacture of a controlled substance, the control of |
---|
155 | | - | which is necessary to prevent, curtail or limit manufacture. |
---|
156 | | - | (i) "Isomer" means all enantiomers and diastereomers. |
---|
157 | | - | (j) "Manufacture" means the production, preparation, propagation, |
---|
158 | | - | compounding, conversion or processing of or placing into pill or |
---|
159 | | - | capsule form a controlled substance either directly or indirectly or by |
---|
160 | | - | extraction from substances of natural origin or independently by means |
---|
161 | | - | of chemical synthesis or by a combination of extraction and chemical |
---|
162 | | - | synthesis. "Manufacture" does not include: |
---|
163 | | - | (1) The preparation or compounding of a controlled substance by |
---|
164 | | - | an individual for the individual's own lawful use or the preparation, |
---|
165 | | - | compounding, packaging or labeling of a controlled substance: |
---|
166 | | - | (A) By a practitioner or the practitioner's agent pursuant to a |
---|
167 | | - | lawful order of a practitioner as an incident to the practitioner's |
---|
168 | | - | administering or dispensing of a controlled substance in the course of |
---|
169 | | - | the practitioner's professional practice; or |
---|
170 | | - | (B) by a practitioner or by the practitioner's authorized agent |
---|
171 | | - | under such practitioner's supervision for the purpose of or as an |
---|
172 | | - | incident to research, teaching or chemical analysis or by a pharmacist |
---|
173 | | - | or medical care facility as an incident to dispensing of a controlled |
---|
174 | | - | substance; or |
---|
175 | | - | (2) the addition of diluents or adulterants, including, but not |
---|
176 | | - | limited to, quinine hydrochloride, mannitol, mannite, dextrose or |
---|
177 | | - | lactose that are intended for use in cutting a controlled substance. |
---|
178 | | - | (k) "Marijuana" means all parts of all varieties of the plant |
---|
179 | | - | Cannabis whether growing or not, the seeds thereof, the resin extracted |
---|
180 | | - | from any part of the plant and every compound, manufacture, salt, |
---|
181 | | - | derivative, mixture or preparation of the plant, its seeds or resin. |
---|
182 | | - | "Marijuana" does not include: |
---|
183 | | - | (1) The mature stalks of the plant, fiber produced from the stalks, |
---|
184 | | - | oil or cake made from the seeds of the plant, any other compound, HOUSE BILL No. 2547—page 4 |
---|
185 | | - | manufacture, salt, derivative, mixture or preparation of the mature |
---|
186 | | - | stalks, except the resin extracted therefrom, fiber, oil or cake or the |
---|
187 | | - | sterilized seed of the plant that is incapable of germination; |
---|
188 | | - | (2) any substance listed in schedules II through V of the uniform |
---|
189 | | - | controlled substances act; |
---|
190 | | - | (3) drug products approved by the United States food and drug |
---|
191 | | - | administration as of the effective date of this act; |
---|
192 | | - | (4) cannabidiol (other trade name: 2-[(3-methyl-6-(1- |
---|
193 | | - | methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or |
---|
194 | | - | (5) industrial hemp as defined in K.S.A. 2-3901, and amendments |
---|
195 | | - | thereto, when cultivated, produced, possessed or used for activities |
---|
196 | | - | authorized by the commercial industrial hemp act. |
---|
197 | | - | (l) "Minor" means a person under 18 years of age. |
---|
198 | | - | (m) "Narcotic drug" means any of the following whether produced |
---|
199 | | - | directly or indirectly by extraction from substances of vegetable origin |
---|
200 | | - | or independently by means of chemical synthesis or by a combination |
---|
201 | | - | of extraction and chemical synthesis: |
---|
202 | | - | (1) Opium and opiate and any salt, compound, derivative or |
---|
203 | | - | preparation of opium or opiate; |
---|
204 | | - | (2) any salt, compound, isomer, derivative or preparation thereof |
---|
205 | | - | that is chemically equivalent or identical with any of the substances |
---|
206 | | - | referred to in paragraph (1) but not including the isoquinoline alkaloids |
---|
207 | | - | of opium; |
---|
208 | | - | (3) opium poppy and poppy straw; |
---|
209 | | - | (4) coca leaves and any salt, compound, derivative or preparation |
---|
210 | | - | of coca leaves and any salt, compound, isomer, derivative or |
---|
211 | | - | preparation thereof that is chemically equivalent or identical with any |
---|
212 | | - | of these substances, but not including decocainized coca leaves or |
---|
213 | | - | extractions of coca leaves that do not contain cocaine or ecgonine. |
---|
214 | | - | (n) "Opiate" means any substance having an addiction-forming or |
---|
215 | | - | addiction-sustaining liability similar to morphine or being capable of |
---|
216 | | - | conversion into a drug having addiction-forming or addiction- |
---|
217 | | - | sustaining liability. "Opiate" does not include, unless specifically |
---|
218 | | - | designated as controlled under K.S.A. 65-4102, and amendments |
---|
219 | | - | thereto, the dextrorotatory isomer of 3-methoxy-n-methylmorphinan |
---|
220 | | - | and its salts (dextromethorphan). "Opiate" does include its racemic and |
---|
221 | | - | levorotatory forms. |
---|
222 | | - | (o) "Opium poppy" means the plant of the species Papaver |
---|
223 | | - | somniferum l. except its seeds. |
---|
224 | | - | (p) "Person" means an individual, corporation, government or |
---|
225 | | - | governmental subdivision or agency, business trust, estate, trust, |
---|
226 | | - | partnership, association or any other legal entity. |
---|
227 | | - | (q) "Poppy straw" means all parts, except the seeds, of the opium |
---|
228 | | - | poppy, after mowing. |
---|
229 | | - | (r) "School property" means property upon which is located a |
---|
230 | | - | structure used by a unified school district or an accredited nonpublic |
---|
231 | | - | school for student instruction or attendance or extracurricular activities |
---|
232 | | - | of pupils enrolled in kindergarten or any of the grades one through 12. |
---|
233 | | - | This definition shall not be construed as requiring that school be in |
---|
234 | | - | session or that classes are actually being held at the time of the offense |
---|
235 | | - | or that children must be present within the structure or on the property |
---|
236 | | - | during the time of any alleged criminal act. If the structure or property |
---|
237 | | - | meets the above definition, the actual use of that structure or property at |
---|
238 | | - | the time alleged shall not be a defense to the crime charged or the |
---|
239 | | - | sentence imposed. |
---|
240 | | - | (s) "Simulated controlled substance" means any product that |
---|
241 | | - | identifies itself by a common name or slang term associated with a |
---|
242 | | - | controlled substance and that indicates on its label or accompanying |
---|
243 | | - | promotional material that the product simulates the effect of a HOUSE BILL No. 2547—page 5 |
---|
244 | | - | controlled substance. |
---|
245 | | - | Sec. 2. K.S.A. 65-1680 is hereby amended to read as follows: 65- |
---|
| 16 | + | Section 1. K.S.A. 65-1680 is hereby amended to read as follows: 65- |
---|
301 | | - | (d) The terms used in this section mean the same as defined in |
---|
302 | | - | K.S.A. 72-6283, and amendments thereto. HOUSE BILL No. 2547—page 6 |
---|
303 | | - | Sec. 4. K.S.A. 2023 Supp. 65-4105 is hereby amended to read as |
---|
304 | | - | follows: 65-4105. (a) The controlled substances listed in this section are |
---|
305 | | - | included in schedule I and the number set forth opposite each drug or |
---|
306 | | - | substance is the DEA controlled substances code that has been assigned |
---|
307 | | - | to it. |
---|
308 | | - | (b) Any of the following opiates, including their isomers, esters, |
---|
309 | | - | ethers, salts, and salts of isomers, esters and ethers, unless specifically |
---|
310 | | - | excepted, whenever the existence of these isomers, esters, ethers and |
---|
311 | | - | salts is possible within the specific chemical designation: |
---|
312 | | - | (1) Acetyl fentanyl |
---|
313 | | - | (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)...9821 |
---|
314 | | - | (2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2- |
---|
315 | | - | phenethyl)-4-piperidinyl]-N-phenylacetamide)............9815 |
---|
316 | | - | (3) Acetylmethadol.............................................................9601 |
---|
317 | | - | (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- |
---|
318 | | - | phenylacrylamide; acryloylfentanyl).............................9811 |
---|
319 | | - | (5) AH-7921 (3,4-dichloro-N-[(1- |
---|
320 | | - | dimethylamino)cyclohexylmethyl]benzamide).............9551 |
---|
321 | | - | (6) Allylprodine..................................................................9602 |
---|
322 | | - | (7) Alphacetylmethadol......................................................9603 |
---|
323 | | - | (except levo-alphacetylmethadol also known as levo-alpha- |
---|
324 | | - | acetylmethadol, levomethadyl acetate or LAAM) |
---|
325 | | - | (8) Alphameprodine............................................................9604 |
---|
326 | | - | (9) Alphamethadol..............................................................9605 |
---|
327 | | - | (10) Alpha′-methyl butyryl fentanyl (2-methyl-N-(1- |
---|
328 | | - | phenethylpiperidin-4-yl)-N-phenylbutanamide)...........9864 |
---|
329 | | - | (11) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta- |
---|
330 | | - | phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2- |
---|
331 | | - | phenylethyl)-4-(N-propanilido) piperidine)..................9814 |
---|
332 | | - | (11)(12)Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl- |
---|
333 | | - | 4-piperidinyl]-N-phenylpropanamide)..........................9832 |
---|
334 | | - | (12)(13)Benzethidine..................................................................9606 |
---|
335 | | - | (13)(14)Betacetylmethadol.........................................................9607 |
---|
336 | | - | (14)(15)Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4- |
---|
337 | | - | piperidinyl]-N-phenylpropanamide).............................9830 |
---|
338 | | - | (15)(16)Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2- |
---|
339 | | - | hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N- |
---|
340 | | - | phenylpropanamide)......................................................9831 |
---|
341 | | - | (16)(17)Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen- |
---|
342 | | - | 2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide)......9836 |
---|
343 | | - | (17)(18)Betameprodine..............................................................9608 |
---|
344 | | - | (18)(19)Betamethadol................................................................9609 |
---|
345 | | - | (20) Beta-methyl fentanyl (N-phenyl-N-(1-(2- |
---|
346 | | - | phenylpropyl)piperidin-4-yl)propionamide; also known as |
---|
347 | | - | β-methyl fentanyl).........................................................9856 |
---|
348 | | - | (21) Beta'-phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N, 3- |
---|
349 | | - | diphenylpropanamide; also known as β'-phenyl fentanyl; |
---|
350 | | - | 3-phenylpropanoyl fentanyl).........................................9842 |
---|
351 | | - | (19)(22)Betaprodine...................................................................9611 |
---|
352 | | - | (23) Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)- |
---|
353 | | - | 1,3-dihydro-2H-benzo[d]imidazol-2-one)....................9098 |
---|
354 | | - | (20)(24)Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- |
---|
355 | | - | phenylbutyramide)........................................................9822 |
---|
356 | | - | (21)(25)Clonitazene....................................................................9612 |
---|
357 | | - | (22)(26)Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N- |
---|
358 | | - | phenylbut-2-enamide)...................................................9844 |
---|
359 | | - | (23)(27)Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- |
---|
360 | | - | phenylcyclopentanecarboxamide).................................9847 |
---|
361 | | - | (24)(28)Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- HOUSE BILL No. 2547—page 7 |
---|
362 | | - | phenylcyclopropanecarboxamide)................................9845 |
---|
363 | | - | (25)(29)Dextromoramide...........................................................9613 |
---|
364 | | - | (26)(30)Diampromide................................................................9615 |
---|
365 | | - | (27)(31)Diethylthiambutene.......................................................9616 |
---|
366 | | - | (28)(32)Difenoxin......................................................................9168 |
---|
367 | | - | (29)(33)Dimenoxadol.................................................................9617 |
---|
368 | | - | (30)(34)Dimepheptanol..............................................................9618 |
---|
369 | | - | (31)(35)2′,5′-Dimethoxyfentanyl (N-(1-(2,5- |
---|
370 | | - | dimethoxyphenethyl)piperidin-4-yl)-N- |
---|
371 | | - | phenylpropionamide)....................................................9861 |
---|
372 | | - | (36) Dimethylthiambutene....................................................9619 |
---|
373 | | - | (32)(37)Dioxaphetyl butyrate.....................................................9621 |
---|
374 | | - | (33)(38)Dipipanone....................................................................9622 |
---|
375 | | - | (34)(39)Ethylmethylthiambutene...............................................9623 |
---|
376 | | - | (35)(40)Etonitazene....................................................................9624 |
---|
377 | | - | (36)(41)Etoxeridine....................................................................9625 |
---|
378 | | - | (37)(42)Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl) |
---|
379 | | - | (phenyl)carbamate).......................................................9851 |
---|
380 | | - | (43) 2′-Fluoro ortho-fluorofentanyl (N-(1-(2- |
---|
381 | | - | fluorophenethyl)piperidin-4-yl)-N-(2- |
---|
382 | | - | fluorophenyl)propionamide; also known as 2′-fluoro 2- |
---|
383 | | - | fluorofentanyl)..............................................................9855 |
---|
384 | | - | (44) Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- |
---|
385 | | - | phenylfuran-2-carboxamide).........................................9834 |
---|
386 | | - | (38)(45)3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- |
---|
387 | | - | phenylfuran-3-carboxamide)........................................9860 |
---|
388 | | - | (46) Furethidine....................................................................9626 |
---|
389 | | - | (39)(47)Hydroxypethidine..........................................................9627 |
---|
390 | | - | (40)(48)Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- |
---|
391 | | - | phenylisobutyramide)...................................................9827 |
---|
392 | | - | (49) Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5- |
---|
393 | | - | nitro-1H-benzimidazol-1-yl)ethan-1-amine; N,N-diethyl-2- |
---|
394 | | - | [[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1 H- |
---|
395 | | - | benzimidazole-1-ethanamine).......................................9614 |
---|
396 | | - | (41) Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- |
---|
397 | | - | phenylisobutyramide) ....................................................9827 |
---|
398 | | - | (42)(50)Isovaleryl fentanyl (3-methyl- N -(1-phenethylpiperidin-4- |
---|
399 | | - | yl)-N-phenylbutanamide)..............................................9862 |
---|
400 | | - | (51) Ketobemidone...............................................................9628 |
---|
401 | | - | (43)(52)Levomoramide..............................................................9629 |
---|
402 | | - | (44)(53)Levophenacylmorphan..................................................9631 |
---|
403 | | - | (45)(54)Meta -Fluorofentanyl (N -(3-fluorophenyl)- N -(1- |
---|
404 | | - | phenethylpiperidin-4-yl)propionamide)........................9857 |
---|
405 | | - | (55) Meta -Fluoroisobutyryl fentanyl ( N -(3-fluorophenyl)- N - |
---|
406 | | - | (1-phenethylpiperidin-4-yl)isobutyramide)..................9858 |
---|
407 | | - | (56) Methoxyacetyl fentanyl (2-methoxy-N-(1- |
---|
408 | | - | phenethylpiperidin-4-yl)-N-phenylacetamide).............9825 |
---|
409 | | - | (57) 4′-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl) |
---|
410 | | - | piperidin-4-yl)-N-phenylacetamide).............................9819 |
---|
411 | | - | (46)(58)3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4- |
---|
412 | | - | piperidyl]-N-phenylpropanamide)................................9813 |
---|
413 | | - | (47)(59)3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4- |
---|
414 | | - | piperidinyl]-N-phenylpropanamide).............................9833 |
---|
415 | | - | (60) Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5- |
---|
416 | | - | nitro-1H-benzimidazol-1-yl)ethan-1-amine)................9757 |
---|
417 | | - | (48)(61)Morpheridine.................................................................9632 |
---|
418 | | - | (49) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1- |
---|
419 | | - | phenethylpiperidin-4-yl)acetamide) ..............................9838 |
---|
420 | | - | (50) O-desmethyltramadol HOUSE BILL No. 2547—page 8 |
---|
421 | | - | Some trade or other names: 2-((dimethylamino)methyl-1- |
---|
422 | | - | (3-hydroxyphenyl)cyclohexanol;3-(2- |
---|
423 | | - | ((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol |
---|
424 | | - | (51)(62)MPPP (1-methyl-4-phenyl-4-propionoxypiperidine)....9661 |
---|
425 | | - | (52)(63)MT-45 (1-cychohexyl-4-(1,2-diphenylethyl) |
---|
426 | | - | piperazine).....................................................................9560 |
---|
427 | | - | (53)(64)Noracymethadol............................................................9633 |
---|
428 | | - | (54)(65)Norlevorphanol.............................................................9634 |
---|
429 | | - | (55)(66)Normethadone...............................................................9635 |
---|
430 | | - | (56)(67)Norpipanone..................................................................9636 |
---|
431 | | - | (68) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1- |
---|
432 | | - | phenethylpiperidin-4-yl) acetamide)............................9838 |
---|
433 | | - | (69) O-desmethyltramadol (Some trade or other names: 2- |
---|
434 | | - | ((dimethylamino)methyl-1-(3-hydroxyphenyl) |
---|
435 | | - | cyclohexanol;3-(2-((dimethylamino)methyl)-1- |
---|
436 | | - | hydroxycyclohexyl)phenol) |
---|
437 | | - | (70) Ortho-fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1- |
---|
438 | | - | phenethylpiperidin-4-yl)acrylamide)............................9852 |
---|
439 | | - | (71) Ortho-fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- |
---|
440 | | - | phenethylpiperidin-4-yl)butyramide; also known as 2- |
---|
441 | | - | fluorobutyryl fentanyl)..................................................9846 |
---|
442 | | - | (57)(72)Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1- |
---|
443 | | - | phenethylpiperidin-4-yl)propionamide; |
---|
444 | | - | 2-fluorofentanyl)...........................................................9816 |
---|
445 | | - | (73) Ortho -Fluorofuranyl fentanyl ( N -(2-fluorophenyl)- N - |
---|
446 | | - | (1-phenethylpiperidin-4-yl)furan-2-carboxamide).......9863 |
---|
447 | | - | (74) (Ortho-fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- |
---|
448 | | - | phenethylpiperidin-4-yl)isobutyramide).......................9853 |
---|
449 | | - | (75) Ortho-methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- |
---|
450 | | - | phenethylpiperidin-4-yl)acetamide; also known as 2- |
---|
451 | | - | methyl acetylfentanyl)...................................................9848 |
---|
452 | | - | (76) Ortho-methyl methoxyacetyl fentanyl (2-methoxy-N-(2- |
---|
453 | | - | methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; |
---|
454 | | - | also known as 2-methyl methoxyacetyl fentanyl)..........9820 |
---|
455 | | - | (58)(77)Para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1- |
---|
456 | | - | phenethylpiperidin-4-yl)isobutyramide).......................9826 |
---|
457 | | - | (59)(78)Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1- |
---|
458 | | - | phenethylpiperidin-4-yl)butyramide)............................9823 |
---|
459 | | - | (60)(79)Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2- |
---|
460 | | - | phenethyl)-4-piperidinyl]propanamide)........................9812 |
---|
461 | | - | (61)(80)Para-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1- |
---|
462 | | - | phenethylpiperidin-4-yl)isobutyramide, 4-fluoroisobutyryl |
---|
463 | | - | fentanyl)........................................................................9824 |
---|
464 | | - | (81) Para-fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1- |
---|
465 | | - | phenethylpiperidin-4-yl)furan-2-carboxamide)............9854 |
---|
466 | | - | (62)(82)Para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N- |
---|
467 | | - | (1-phenethylpiperidin-4-yl)butyramide).......................9837 |
---|
468 | | - | (83) Para -Methoxyfuranyl fentanyl ( N -(4-methoxyphenyl)- N |
---|
469 | | - | -(1-phenethylpiperidin-4-yl)furan-2-carboxamide.......9859 |
---|
470 | | - | (84) para -Methylcyclopropyl fentanyl ( N -(4-methylphenyl)- N |
---|
471 | | - | -(1-phenethylpiperidin-4-yl) |
---|
472 | | - | cyclopropanecarboxamide)..........................................9865 |
---|
473 | | - | (85) Para-methylfentanyl (N-(4-methylphenyl)-N-(1- |
---|
474 | | - | phenethylpiperidin-4-yl)propionamide; also known as 4- |
---|
475 | | - | methylfentanyl).............................................................9817 |
---|
476 | | - | (63)(86)PEPAP (1-(-2-phenethyl)-4-phenyl-4- |
---|
477 | | - | acetoxypiperidine).........................................................9663 |
---|
478 | | - | (64)(87)Phenadoxone.................................................................9637 |
---|
479 | | - | (65)(88)Phenampromide............................................................9638 HOUSE BILL No. 2547—page 9 |
---|
480 | | - | (66)(89)Phenomorphan..............................................................9647 |
---|
481 | | - | (67)(90)Phenoperidine................................................................9641 |
---|
482 | | - | (91) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- |
---|
483 | | - | phenylbenzamide; also known as benzoyl fentanyl).....9841 |
---|
484 | | - | (68)(92)Piritramide.....................................................................9642 |
---|
485 | | - | (69)(93)Proheptazine..................................................................9643 |
---|
486 | | - | (70)(94)Properidine....................................................................9644 |
---|
487 | | - | (71)(95)Propiram........................................................................9649 |
---|
488 | | - | (72)(96)Racemoramide..............................................................9645 |
---|
489 | | - | (73)(97)Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)- |
---|
490 | | - | N-phenyltetrahydrofuran-2-carboxamide)....................9843 |
---|
491 | | - | (74)(98)Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4- |
---|
492 | | - | piperidinyl]-propanamide)............................................9835 |
---|
493 | | - | (99) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- |
---|
494 | | - | phenylthiophene-2-carboxamide; also known as 2- |
---|
495 | | - | thiofuranyl fentanyl; thiophene fentanyl).....................9839 |
---|
496 | | - | (75)(100)Tilidine..........................................................................9750 |
---|
497 | | - | (76)(101)Trimeperidine................................................................9646 |
---|
498 | | - | (77)(102)U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]- |
---|
499 | | - | N-methylbenzamide).....................................................9547 |
---|
500 | | - | (78)(103)Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- |
---|
501 | | - | phenylpentanamide)......................................................9840 |
---|
502 | | - | (104) Zipeprol (1-methoxy-3-[4-(2-methoxy-2- |
---|
503 | | - | phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol)......9873 |
---|
504 | | - | (c) Any of the following opium derivatives, their salts, isomers |
---|
505 | | - | and salts of isomers, unless specifically excepted, whenever the |
---|
506 | | - | existence of these salts, isomers and salts of isomers is possible within |
---|
507 | | - | the specific chemical designation: |
---|
508 | | - | (1) Acetorphine...................................................................9319 |
---|
509 | | - | (2) Acetyldihydrocodeine...................................................9051 |
---|
510 | | - | (3) Benzylmorphine............................................................9052 |
---|
511 | | - | (4) Brorphine ......................................................................9098 |
---|
512 | | - | (5) Codeine methylbromide................................................9070 |
---|
513 | | - | (6)(5) Codeine-N-Oxide..........................................................9053 |
---|
514 | | - | (7)(6) Cyprenorphine...............................................................9054 |
---|
515 | | - | (8)(7) Desomorphine...............................................................9055 |
---|
516 | | - | (9)(8) Dihydromorphine..........................................................9145 |
---|
517 | | - | (10)(9)Drotebanol.....................................................................9335 |
---|
518 | | - | (11)(10)Etorphine (except hydrochloride salt)...........................9056 |
---|
519 | | - | (12)(11)Heroin............................................................................9200 |
---|
520 | | - | (13)(12)Hydromorphinol............................................................9301 |
---|
521 | | - | (14)(13)Methyldesorphine..........................................................9302 |
---|
522 | | - | (15)(14)Methyldihydromorphine...............................................9304 |
---|
523 | | - | (16)(15)Morphine methylbromide.............................................9305 |
---|
524 | | - | (17)(16)Morphine methylsulfonate............................................9306 |
---|
525 | | - | (18)(17)Morphine-N-Oxide........................................................9307 |
---|
526 | | - | (19)(18)Myrophine.....................................................................9308 |
---|
527 | | - | (20)(19)Nicocodeine..................................................................9309 |
---|
528 | | - | (21)(20)Nicomorphine................................................................9312 |
---|
529 | | - | (22)(21)Normorphine.................................................................9313 |
---|
530 | | - | (23)(22)Pholcodine.....................................................................9314 |
---|
531 | | - | (24)(23)Thebacon.......................................................................9315 |
---|
532 | | - | (d) Any material, compound, mixture or preparation that contains |
---|
533 | | - | any quantity of the following hallucinogenic substances, their salts, |
---|
534 | | - | isomers and salts of isomers, unless specifically excepted, whenever |
---|
535 | | - | the existence of these salts, isomers and salts of isomers is possible |
---|
536 | | - | within the specific chemical designation: |
---|
537 | | - | (1) Alpha-ethyltryptamine .................................................7249 |
---|
538 | | - | Some trade or other names: etryptamine; Monase; α-ethyl- HOUSE BILL No. 2547—page 10 |
---|
539 | | - | 1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; |
---|
540 | | - | and AET. |
---|
541 | | - | (2) 4-bromo-2,5-dimethoxy-amphetamine.........................7391 |
---|
542 | | - | Some trade or other names: 4-bromo-2,5-dimethoxy-alpha- |
---|
543 | | - | methylphenethylamine; 4-bromo-2,5-DMA. |
---|
544 | | - | (3) 2,5-dimethoxyamphetamine..........................................7396 |
---|
545 | | - | Some trade or other names: 2,5-dimethoxy-alpha-methyl- |
---|
546 | | - | phenethylamine; 2,5-DMA. |
---|
547 | | - | (4) 4-methoxyamphetamine................................................7411 |
---|
548 | | - | Some trade or other names: 4-methoxy-alpha- |
---|
549 | | - | methylphene-thylamine; paramethoxyamphetamine; PMA. |
---|
550 | | - | (5) 5-methoxy-3,4-methylenedioxy-amphetamine.............7401 |
---|
551 | | - | (6) 4-methyl-2,5-dimethoxy-amphetamine.........................7395 |
---|
552 | | - | Some trade or other names: 4-methyl-2,5-dimethoxy- |
---|
553 | | - | alpha-methylphenethylamine; "DOM"; and "STP". |
---|
554 | | - | (7) 3,4-methylenedioxy amphetamine................................7400 |
---|
555 | | - | (8) 3,4-methylenedioxymethamphetamine (MDMA).........7405 |
---|
556 | | - | (9) 3,4-methylenedioxy-N-ethylamphetamine (also known as |
---|
557 | | - | N-ethyl-alpha-methyl-3,4 (methylenedioxy) |
---|
558 | | - | phenethylamine, N-ethyl MDA, MDE, and MDEA)....7404 |
---|
559 | | - | (10) N-hydroxy-3,4-methylenedioxyamphetamine (also known |
---|
560 | | - | as N-hydroxy-alpha-methyl-3,4-(methylenedioxy) |
---|
561 | | - | phenethylamine, and N-hydroxy MDA).......................7402 |
---|
562 | | - | (11) 3,4,5-trimethoxy amphetamine.....................................7390 |
---|
563 | | - | (12) Bufotenine.....................................................................7433 |
---|
564 | | - | Some trade or other names: 3-(Beta-Dimethylaminoethyl)- |
---|
565 | | - | 5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, |
---|
566 | | - | N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; |
---|
567 | | - | mappine. |
---|
568 | | - | (13) Diethyltryptamine.........................................................7434 |
---|
569 | | - | Some trade or other names: N,N-Diethyltryptamine; DET. |
---|
570 | | - | (14) Dimethyltryptamine......................................................7435 |
---|
571 | | - | Some trade or other names: DMT. |
---|
572 | | - | (15) Ibogaine.........................................................................7260 |
---|
573 | | - | Some trade or other names: 7-Ethyl-6,6 |
---|
574 | | - | Beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano- |
---|
575 | | - | 5H-pyrido[1',2':1,2]azepino[5,4-b]indole; Tabernanthe |
---|
576 | | - | iboga |
---|
577 | | - | (16) Lysergic acid diethylamide...........................................7315 |
---|
578 | | - | (17) Marijuana......................................................................7360 |
---|
579 | | - | (18) Mescaline......................................................................7381 |
---|
580 | | - | (19) Parahexyl.......................................................................7374 |
---|
581 | | - | Some trade or other names: 3-Hexyl-l-hydroxy-7,8,9,10- |
---|
582 | | - | tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; |
---|
583 | | - | Synhexyl. |
---|
584 | | - | (20) Peyote............................................................................7415 |
---|
585 | | - | Meaning all parts of the plant presently classified |
---|
586 | | - | botanically as Lophophora williamsii Lemaire, whether |
---|
587 | | - | growing or not, the seeds thereof, any extract from any part |
---|
588 | | - | of such plant, and every compound, manufacture, salts, |
---|
589 | | - | derivative, mixture or preparation of such plant, its seeds |
---|
590 | | - | or extracts. |
---|
591 | | - | (21) N-ethyl-3-piperidyl benzilate........................................7482 |
---|
592 | | - | (22) N-methyl-3-piperidyl benzilate.....................................7484 |
---|
593 | | - | (23) Psilocybin......................................................................7437 |
---|
594 | | - | (24) Psilocyn.........................................................................7438 |
---|
595 | | - | Some trade or other names: Psilocin. |
---|
596 | | - | (25) Ethylamine analog of phencyclidine.............................7455 |
---|
597 | | - | Some trade or other names: N-ethyl-1-phenyl-cyclo- HOUSE BILL No. 2547—page 11 |
---|
598 | | - | hexylamine; (1-phenylcyclohexyl)ethylamine; N-(1- |
---|
599 | | - | phenylcyclohexyl)ethylamine; cyclohexamine; PCE. |
---|
600 | | - | (26) Pyrrolidine analog of phencyclidine.............................7458 |
---|
601 | | - | Some trade or other names: 1-(1-phenylcyclohexyl)- |
---|
602 | | - | pyrrolidine; PCPy; PHP. |
---|
603 | | - | (27) Thiophene analog of phencyclidine..............................7470 |
---|
604 | | - | Some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]- |
---|
605 | | - | piperidine; 2-thienyl analog of phencyclidine; TPCP; TCP. |
---|
606 | | - | (28) 1-[1-(2-thienyl)-cyclohexyl] pyrrolidine.......................7473 |
---|
607 | | - | Some other names: TCPy. |
---|
608 | | - | (29) 2,5-dimethoxy-4-ethylamphetamine.............................7399 |
---|
609 | | - | Some trade or other names: DOET. |
---|
610 | | - | (30) Salvia divinorum or salvinorum A; all parts of the plant |
---|
611 | | - | presently classified botanically as salvia divinorum, |
---|
612 | | - | whether growing or not, the seeds thereof, any extract from |
---|
613 | | - | any part of such plant, and every compound, manufacture, |
---|
614 | | - | salts, derivative, mixture or preparation of such plant, its |
---|
615 | | - | seeds or extracts. |
---|
616 | | - | (31) Datura stramonium, commonly known as gypsum weed or |
---|
617 | | - | jimson weed; all parts of the plant presently classified |
---|
618 | | - | botanically as datura stramonium, whether growing or not, |
---|
619 | | - | the seeds thereof, any extract from any part of such plant, |
---|
620 | | - | and every compound, manufacture, salts, derivative, |
---|
621 | | - | mixture or preparation of such plant, its seeds or extracts. |
---|
622 | | - | (32) N-benzylpiperazine .......................................................7493 |
---|
623 | | - | Some trade or other names: BZP. |
---|
624 | | - | (33) 1-(3-[trifluoromethylphenyl])piperazine |
---|
625 | | - | Some trade or other names: TFMPP. |
---|
626 | | - | (34)(33)4-Bromo-2,5-dimethoxyphenethylamine......................7392 |
---|
627 | | - | (35)(34)2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), |
---|
628 | | - | its optical isomers, salts and salts of optical isomers....7348 |
---|
629 | | - | (36)(35)Alpha-methyltryptamine (other name: AMT)...............7432 |
---|
630 | | - | (37)(36)5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its |
---|
631 | | - | isomers, salts and salts of isomers................................7439 |
---|
632 | | - | (38)(37)2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E). .7509 |
---|
633 | | - | (39)(38)2-(2,5-Dimethoxy-4-methylphenyl)ethanamine |
---|
634 | | - | (2C-D)...........................................................................7508 |
---|
635 | | - | (40)(39)2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)7519 |
---|
636 | | - | (41)(40)2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).....7518 |
---|
637 | | - | (42)(41)2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine |
---|
638 | | - | (2C-T-2).........................................................................7385 |
---|
639 | | - | (43)(42)2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] |
---|
640 | | - | ethanamine (2C-T-4).....................................................7532 |
---|
641 | | - | (44)(43)2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)..............7517 |
---|
642 | | - | (45)(44)2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine (2C-N). .7521 |
---|
643 | | - | (46)(45)2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine |
---|
644 | | - | (2C-P)............................................................................7524 |
---|
645 | | - | (47)(46)5–methoxy–N,N–dimethyltryptamine (5–MeO–DMT)7431 |
---|
646 | | - | Some trade or other names: 5–methoxy–3–[2– |
---|
647 | | - | (dimethylamino) ethyl]indole. |
---|
648 | | - | (48)(47)2–(4–iodo–2,5–dimethoxyphenyl)–N–(2– |
---|
649 | | - | methoxybenzyl)ethanamine..........................................7538 |
---|
650 | | - | Some trade or other names: 25I–NBOMe; 2C–I–NBOMe; |
---|
651 | | - | 25I; Cimbi–5. |
---|
652 | | - | (49)(48)2–(4–chloro–2,5–dimethoxyphenyl)–N–(2– |
---|
653 | | - | methoxybenzyl)ethanamine..........................................7537 |
---|
654 | | - | Some trade or other names: 25C–NBOMe; 2C–C– |
---|
655 | | - | NBOMe; 25C; Cimbi–82. |
---|
656 | | - | (50)(49)2–(4–bromo–2,5–dimethoxyphenyl)–N–(2– HOUSE BILL No. 2547—page 12 |
---|
657 | | - | methoxybenzyl)ethanamine..........................................7536 |
---|
658 | | - | Some trade or other names: 25B–NBOMe; 2C–B– |
---|
659 | | - | NBOMe; 25B; Cimbi–36. |
---|
660 | | - | (51)(50)2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
---|
661 | | - | Some trade or other names: 25H-NBOMe. |
---|
662 | | - | (52)(51)2-(2,5-dimethoxy-4-methylphenyl)-N-(2- |
---|
663 | | - | methoxybenzyl)ethanamine |
---|
664 | | - | Some trade or other names: 25D-NBOMe; 2C-D-NBOMe. |
---|
665 | | - | (53)(52)2-(2,5-dimethoxy-4-nitrophenyl)-N-(2- |
---|
666 | | - | methoxybenzyl)ethanamine |
---|
667 | | - | Some trade or other names: 25N-NBOMe, 2C-N-NBOMe. |
---|
668 | | - | (54)(53)1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H- |
---|
669 | | - | pyrrolo[2,3-b]pyridine-3-carboxamide (5F-CUMYL- |
---|
670 | | - | P7AICA).......................................................................7085 |
---|
671 | | - | (54) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one |
---|
672 | | - | (other names: methoxetamine, MXE)...........................7286 |
---|
673 | | - | (55) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other |
---|
674 | | - | names: para-methoxymethamphetamine, PMMA) ......1245 |
---|
675 | | - | (e) Any material, compound, mixture or preparation that contains |
---|
676 | | - | any quantity of the following substances having a depressant effect on |
---|
677 | | - | the central nervous system, including its salts, isomers, and salts of |
---|
678 | | - | isomers whenever the existence of such salts, isomers, and salts of |
---|
679 | | - | isomers is possible within the specific chemical designation: |
---|
680 | | - | (1) Etizolam........................................................................2780 |
---|
681 | | - | Some trade or other names: (4-(2-chlorophenyl)-2-ethyl-9- |
---|
682 | | - | methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a] |
---|
683 | | - | [1,4]diazepine) |
---|
684 | | - | (2) Mecloqualone................................................................2572 |
---|
685 | | - | (3) Methaqualone................................................................2565 |
---|
686 | | - | (4) Gamma hydroxybutyric acid........................................2010 |
---|
687 | | - | (5) 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f] |
---|
688 | | - | [1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, |
---|
689 | | - | and salts of isomers |
---|
690 | | - | (other name: flualprazolam).........................................2785 |
---|
691 | | - | (6) 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f] |
---|
692 | | - | [1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, |
---|
693 | | - | and salts of isomers (other name: clonazolam)............2786 |
---|
694 | | - | (7) 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f] |
---|
695 | | - | [1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, |
---|
696 | | - | and salts of isomers |
---|
697 | | - | (other name: flubromazolam).......................................2788 |
---|
698 | | - | (8) 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H- |
---|
699 | | - | benzo[e][1,4]diazepin-2-one, its salts, isomers, and salts |
---|
700 | | - | of isomers (other name: diclazepam)...........................2789 |
---|
701 | | - | (f) Unless specifically excepted or unless listed in another |
---|
702 | | - | schedule, any material, compound, mixture or preparation that contains |
---|
703 | | - | any quantity of the following substances having a stimulant effect on |
---|
704 | | - | the central nervous system, including its salts, isomers and salts of |
---|
705 | | - | isomers: |
---|
706 | | - | (1) Aminorex......................................................................1585 |
---|
707 | | - | Some other names: Aminoxaphen 2-amino-5-phenyl-2- |
---|
708 | | - | oxazoline or 4,5-dihydro-5-phenyl-2-oxazolamine |
---|
709 | | - | (2) Fenethylline...................................................................1503 |
---|
710 | | - | (3) N-ethylamphetamine.....................................................1475 |
---|
711 | | - | (4) (+)cis-4-methylaminorex ((+)cis-4,5-dihydro-4-methyl-5- |
---|
712 | | - | phenyl-2-oxazolamine).................................................1590 |
---|
713 | | - | (5) N,N-dimethylamphetamine (also known as N,N-alpha- |
---|
714 | | - | trimethyl-benzeneethanamine; N,N-alpha- |
---|
715 | | - | trimethylphenethylamine).............................................1480 HOUSE BILL No. 2547—page 13 |
---|
716 | | - | (6) Cathinone (some other names: 2-amino-1-phenol-1- |
---|
717 | | - | propanone, alpha-amino propiophenone, 2-amino |
---|
718 | | - | propiophenone and norphedrone).................................1235 |
---|
719 | | - | (7) Substituted cathinones |
---|
720 | | - | Any compound, except bupropion or compounds listed |
---|
721 | | - | under a different schedule, structurally derived from 2– |
---|
722 | | - | aminopropan–1–one by substitution at the 1-position with |
---|
723 | | - | either phenyl, naphthyl, or thiophene ring systems, whether |
---|
724 | | - | or not the compound is further modified in any of the |
---|
725 | | - | following ways: |
---|
726 | | - | (A) By substitution in the ring system to any extent with |
---|
727 | | - | alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide |
---|
728 | | - | substituents, whether or not further substituted in the ring |
---|
729 | | - | system by one or more other univalent substituents; |
---|
730 | | - | (B) by substitution at the 3-position with an acyclic alkyl |
---|
731 | | - | substituent; |
---|
732 | | - | (C)by substitution at the 2-amino nitrogen atom with alkyl, |
---|
733 | | - | dialkyl, benzyl, or methoxybenzyl groups; or |
---|
734 | | - | (D) by inclusion of the 2-amino nitrogen atom in a cyclic |
---|
735 | | - | structure. |
---|
736 | | - | (8) N-benzylpiperazine (other names: BZP, |
---|
737 | | - | 1-benzylpiprazine)........................................................7493 |
---|
738 | | - | (9) Methiopropamine |
---|
739 | | - | (N-methyl-1-(thiophen-2-yl)propan-2-amine)..............1478 |
---|
740 | | - | (10) 4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4- |
---|
741 | | - | methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4- |
---|
742 | | - | methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)..........1595 |
---|
743 | | - | (11) Amineptine (7-[(10,11-dihydro-5 H-dibenzo[a,d] |
---|
744 | | - | cyclohepten-5-yl)amino]heptanoic acid)......................1219 |
---|
745 | | - | (12) Mesocarb (N-phenyl-N ′-(3-(1-phenylpropan-2-yl)-1,2,3- |
---|
746 | | - | oxadiazol-3-ium-5-yl)carbamimidate)..........................1227 |
---|
747 | | - | (g) Any material, compound, mixture or preparation that contains |
---|
748 | | - | any quantity of the following substances: |
---|
749 | | - | (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide |
---|
750 | | - | (benzylfentanyl), its optical isomers, salts and salts of |
---|
751 | | - | isomers |
---|
752 | | - | (2) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide |
---|
753 | | - | (thenylfentanyl), its optical isomers, salts and salts of |
---|
754 | | - | isomers |
---|
755 | | - | (3) Tianeptine, its optical isomers, salts and salts of isomers |
---|
756 | | - | (h) Any of the following cannabinoids, their salts, isomers and |
---|
757 | | - | salts of isomers, unless specifically excepted, whenever the existence of |
---|
758 | | - | these salts, isomers and salts of isomers is possible within the specific |
---|
759 | | - | chemical designation: |
---|
760 | | - | (1) Tetrahydrocannabinols..................................................7370 |
---|
761 | | - | Meaning tetrahydrocannabinols naturally contained in a |
---|
762 | | - | plant of the genus Cannabis (cannabis plant), as well as |
---|
763 | | - | synthetic equivalents of the substances contained in the |
---|
764 | | - | plant, or in the resinous extractives of Cannabis, sp. and/or |
---|
765 | | - | synthetic substances, derivatives, and their isomers with |
---|
766 | | - | similar chemical structure and pharmacological activity |
---|
767 | | - | such as the following: Delta 1 cis or trans |
---|
768 | | - | tetrahydrocannabinol, and their optical isomers Delta 6 cis |
---|
769 | | - | or trans tetrahydrocannabinol, and their optical isomers |
---|
770 | | - | Delta 3,4 cis or trans tetrahydrocannabinol, and its optical |
---|
771 | | - | isomers (Since nomenclature of these substances is not |
---|
772 | | - | internationally standardized, compounds of these |
---|
773 | | - | structures, regardless of numerical designation of atomic |
---|
774 | | - | positions covered.), except tetrahydrocannabinols in any of HOUSE BILL No. 2547—page 14 |
---|
775 | | - | the following: |
---|
776 | | - | (A) Industrial hemp, as defined in K.S.A. 2-3901, and |
---|
777 | | - | amendments thereto; |
---|
778 | | - | (B) solid waste, as defined in K.S.A. 65-3402, and |
---|
779 | | - | amendments thereto, and hazardous waste, as defined in |
---|
780 | | - | K.S.A. 65-3430, and amendments thereto, if such waste is |
---|
781 | | - | the result of the cultivation, production or processing of |
---|
782 | | - | industrial hemp, as defined in K.S.A. 2-3901, and |
---|
783 | | - | amendments thereto, and such waste contains a delta-9 |
---|
784 | | - | tetrahydrocannabinol concentration of not more than 0.3%; |
---|
785 | | - | or |
---|
786 | | - | (C) hemp products, as defined in K.S.A. 2-3901, and |
---|
787 | | - | amendments thereto, unless otherwise deemed unlawful |
---|
788 | | - | pursuant to K.S.A. 2-3908, and amendments thereto. |
---|
789 | | - | (2) Naphthylmethylindoles |
---|
790 | | - | Any compound containing a 1H-indol-3-yl-(1- |
---|
791 | | - | naphthyl)methane structure with substitution at the |
---|
792 | | - | nitrogen atom of the indole group by an alkyl, haloalkyl, |
---|
793 | | - | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, |
---|
794 | | - | benzyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4- |
---|
795 | | - | morpholinyl)ethyl group whether or not further substituted |
---|
796 | | - | on the indole group to any extent and whether or not |
---|
797 | | - | substituted on the benzyl or naphthyl ring to any extent. |
---|
798 | | - | (3) Naphthoylpyrroles |
---|
799 | | - | Any compound containing a 3-(1-naphthoyl)pyrrole |
---|
800 | | - | structure with substitution at the nitrogen atom of the |
---|
801 | | - | pyrrole group by an alkyl, haloalkyl, cyanoalkyl, alkenyl, |
---|
802 | | - | cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2- |
---|
803 | | - | piperidinyl)methyl or 2-(4-morpholinyl)ethyl group |
---|
804 | | - | whether or not further substituted on the pyrrole group to |
---|
805 | | - | any extent, whether or not substituted on the benzyl or |
---|
806 | | - | naphthyl ring to any extent. |
---|
807 | | - | (4) Naphthylmethylindenes |
---|
808 | | - | Any compound containing a naphthylmethylindene |
---|
809 | | - | structure with substitution at the 3-position of the indene |
---|
810 | | - | group by an alkyl, haloalkyl, cyanoalkyl, alkenyl, |
---|
811 | | - | cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2- |
---|
812 | | - | piperidinyl)methyl or 2-(4-morpholinyl)ethyl group |
---|
813 | | - | whether or not further substituted on the indene group to |
---|
814 | | - | any extent, whether or not substituted on the benzyl or |
---|
815 | | - | naphthyl ring to any extent. |
---|
816 | | - | (5) Cyclohexylphenols |
---|
817 | | - | Any compound containing a 2-(3- |
---|
818 | | - | hydroxycyclohexyl)phenol structure with substitution at |
---|
819 | | - | the 5-position of the phenolic ring by an alkyl, haloalkyl, |
---|
820 | | - | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1- |
---|
821 | | - | (N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl |
---|
822 | | - | group whether or not substituted on the cyclohexyl ring to |
---|
823 | | - | any extent. |
---|
824 | | - | (6) 2,3-Dihydro-5-methyl-3-(4- |
---|
825 | | - | morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6- |
---|
826 | | - | yl]-1-napthalenylmethanone. |
---|
827 | | - | Some trade or other names: WIN 55,212-2. |
---|
828 | | - | (7) 9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)- |
---|
829 | | - | 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol |
---|
830 | | - | Some trade or other names: HU-210, HU-211. |
---|
831 | | - | (8) Indole-3-carboxylate esters |
---|
832 | | - | Any compound containing a 1H-indole-3-carboxylate ester |
---|
833 | | - | structure with the ester oxygen bearing a naphthyl, HOUSE BILL No. 2547—page 15 |
---|
834 | | - | quinolinyl, isoquinolinyl or adamantyl group and |
---|
835 | | - | substitution at the 1 position of the indole ring by an alkyl, |
---|
836 | | - | haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, |
---|
837 | | - | cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl |
---|
838 | | - | or 2-(4-morpholinyl)ethyl group, whether or not further |
---|
839 | | - | substituted on the indole ring to any extent and whether or |
---|
840 | | - | not substituted on the naphthyl, quinolinyl, isoquinolinyl, |
---|
841 | | - | adamantyl or benzyl groups to any extent. |
---|
842 | | - | (9) Indazole-3-carboxamides |
---|
843 | | - | Any compound containing a 1H-indazole-3-carboxamide |
---|
844 | | - | structure with substitution at the nitrogen of the |
---|
845 | | - | carboxamide by a naphthyl, quinolinyl, isoquinolinyl, |
---|
846 | | - | adamantyl, benzyl, 1-amino-1-oxoalkan-2-yl or 1-alkoxy- |
---|
847 | | - | 1-oxoalkan-2-yl group and substitution at the 1 position of |
---|
848 | | - | the indazole ring by an alkyl, haloalkyl, cyanoalkyl, |
---|
849 | | - | alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N- |
---|
850 | | - | methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl |
---|
851 | | - | group, whether or not further substituted on the indazole |
---|
852 | | - | ring to any extent and whether or not substituted on the |
---|
853 | | - | naphthyl, quinolinyl, isoquinolinyl, adamantyl, 1-amino-1- |
---|
854 | | - | oxoalkan-2-yl, 1-alkoxy-1-oxoalkan-2-yl or benzyl groups |
---|
855 | | - | to any extent. |
---|
856 | | - | (10) Indole-3-carboxamides |
---|
857 | | - | Any compound containing a 1H-indole-3-carboxamide |
---|
858 | | - | structure with substitution at the nitrogen of the |
---|
859 | | - | carboxamide by a naphthyl, quinolinyl, isoquinolinyl, |
---|
860 | | - | adamantyl, benzyl, 1-amino-1-oxoalkan-2-yl or 1-alkoxy- |
---|
861 | | - | 1-oxoalkan-2-yl group and substitution at the 1 position of |
---|
862 | | - | the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, |
---|
863 | | - | cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2- |
---|
864 | | - | piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, |
---|
865 | | - | whether or not further substituted on the indole ring to any |
---|
866 | | - | extent and whether or not further substituted on the |
---|
867 | | - | naphthyl, quinolinyl, isoquinolinyl, adamantyl, 1-amino-1- |
---|
868 | | - | oxoalkan-2-yl, 1-alkoxy-1-oxoalkan-2-yl or benzyl groups |
---|
869 | | - | to any extent. |
---|
870 | | - | (11) (1H-indazol-3-yl)methanones |
---|
871 | | - | Any compound containing a (1H-indazol-3-yl)methanone |
---|
872 | | - | structure with the carbonyl carbon bearing a naphthyl |
---|
873 | | - | group and substitution at the 1 position of the indazole ring |
---|
874 | | - | by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, |
---|
875 | | - | cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl, |
---|
876 | | - | or 2-(4-morpholinyl)ethyl group, whether or not further |
---|
877 | | - | substituted on the indazole ring to any extent and whether |
---|
878 | | - | or not substituted on the naphthyl or benzyl groups to any |
---|
879 | | - | extent. |
---|
880 | | - | (12) (1H-indol-3-yl)methanones |
---|
881 | | - | Any compound containing a (1H-indol-3-yl)methanone |
---|
882 | | - | structure with the carbonyl carbon bearing a naphthyl, |
---|
883 | | - | quinolinyl, isoquinolinyl, adamantyl, phenyl, benzyl or |
---|
884 | | - | tetramethylcyclopropyl group and substitution at the 1 |
---|
885 | | - | position of the indole ring by an alkyl,haloalkyl, |
---|
886 | | - | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, |
---|
887 | | - | benzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4- |
---|
888 | | - | morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1- |
---|
889 | | - | (N-methyl-3-morpholinyl)methyl, or |
---|
890 | | - | tetrahydropyranylmethyl group, whether or not further |
---|
891 | | - | substituted on the indole ring to any extent and whether or |
---|
892 | | - | not substituted on the naphthyl, quinolinyl, isoquinolinyl, HOUSE BILL No. 2547—page 16 |
---|
893 | | - | adamantyl, phenyl, benzyl or tetramethylcyclopropyl |
---|
894 | | - | groups to any extent. |
---|
895 | | - | Sec. 5. K.S.A. 2023 Supp. 65-4107 is hereby amended to read as |
---|
896 | | - | follows: 65-4107. (a) The controlled substances listed in this section are |
---|
897 | | - | included in schedule II and the number set forth opposite each drug or |
---|
898 | | - | substance is the DEA controlled substances code which has been |
---|
899 | | - | assigned to it. |
---|
900 | | - | (b) Any of the following substances, except those narcotic drugs |
---|
901 | | - | listed in other schedules, whether produced directly or indirectly by |
---|
902 | | - | extraction from substances of vegetable origin or independently by |
---|
903 | | - | means of chemical synthesis or by combination of extraction and |
---|
904 | | - | chemical synthesis: |
---|
905 | | - | (1) Opium and opiate and any salt, compound, derivative or |
---|
906 | | - | preparation of opium or opiate, excluding apomorphine, thebaine- |
---|
907 | | - | derived butorphanol, dextrorphan, nalbuphine, naldemedine, |
---|
908 | | - | nalmefene, naloxegol, naloxone, 6β-naltrexol and, naltrexone and |
---|
909 | | - | samidorphen and their respective salts, but including the following: |
---|
910 | | - | (A) Raw opium....................................................................9600 |
---|
911 | | - | (B) Opium extracts..............................................................9610 |
---|
912 | | - | (C) Opium fluid...................................................................9620 |
---|
913 | | - | (D) Powdered opium...........................................................9639 |
---|
914 | | - | (E) Granulated opium..........................................................9640 |
---|
915 | | - | (F) Tincture of opium..........................................................9630 |
---|
916 | | - | (G) Codeine.........................................................................9050 |
---|
917 | | - | (H) Ethylmorphine...............................................................9190 |
---|
918 | | - | (I) Etorphine hydrochloride...............................................9059 |
---|
919 | | - | (J) Hydrocodone.................................................................9193 |
---|
920 | | - | (K) Hydromorphone............................................................9150 |
---|
921 | | - | (L) Metopon........................................................................9260 |
---|
922 | | - | (M) Morphine.......................................................................9300 |
---|
923 | | - | (N) Noroxymorphone..........................................................9668 |
---|
924 | | - | (O) Oxycodone....................................................................9143 |
---|
925 | | - | (P) Oxymorphone................................................................9652 |
---|
926 | | - | (Q) Thebaine........................................................................9333 |
---|
927 | | - | (R) Dihydroetorphine..........................................................9334 |
---|
928 | | - | (S) Oripavine.......................................................................9330 |
---|
929 | | - | (2) Any salt, compound, isomer, derivative or preparation thereof |
---|
930 | | - | which is chemically equivalent or identical with any of the substances |
---|
931 | | - | referred to in paragraph (1), but not including the isoquinoline alkaloids |
---|
932 | | - | of opium. |
---|
933 | | - | (3) Opium poppy and poppy straw. |
---|
934 | | - | (4) Coca leaves (9040) and any salt, compound, derivative or |
---|
935 | | - | preparation of coca leaves, but not including decocainized coca leaves |
---|
936 | | - | or extractions which do not contain cocaine (9041) or ecgonine (9180). |
---|
937 | | - | (5) Cocaine, its salts, isomers and salts of isomers (9041). |
---|
938 | | - | (6) Ecgonine, its salts, isomers and salts of isomers (9180). |
---|
939 | | - | (7) Concentrate of poppy straw (the crude extract of poppy straw |
---|
940 | | - | in either liquid, solid or powder form which contains the phenanthrene |
---|
941 | | - | alkaloids of the opium poppy) (9670). |
---|
942 | | - | (c) Any of the following opiates, including their isomers, esters, |
---|
943 | | - | ethers, salts and salts of isomers, esters and ethers, whenever the |
---|
944 | | - | existence of these isomers, esters, ethers and salts is possible within the |
---|
945 | | - | specific chemical designation dextrorphan and levopropoxyphene |
---|
946 | | - | excepted: |
---|
947 | | - | (1) Alfentanil......................................................................9737 |
---|
948 | | - | (2) Alphaprodine.................................................................9010 |
---|
949 | | - | (3) Anileridine....................................................................9020 |
---|
950 | | - | (4) Bezitramide...................................................................9800 |
---|
951 | | - | (5) Bulk dextropropoxyphene (nondosage forms)..............9273 HOUSE BILL No. 2547—page 17 |
---|
952 | | - | (6) Carfentanil.....................................................................9743 |
---|
953 | | - | (7) Dihydrocodeine.............................................................9120 |
---|
954 | | - | (8) Diphenoxylate...............................................................9170 |
---|
955 | | - | (9) Fentanyl.........................................................................9801 |
---|
956 | | - | (10) Isomethadone................................................................9226 |
---|
957 | | - | (11) Levomethorphan...........................................................9210 |
---|
958 | | - | (12) Levorphanol..................................................................9220 |
---|
959 | | - | (13) Metazocine....................................................................9240 |
---|
960 | | - | (14) Methadone.....................................................................9250 |
---|
961 | | - | (15) Methadone-intermediate,4-cyano-2-dimethyl amino-4,4- |
---|
962 | | - | diphenyl butane.............................................................9254 |
---|
963 | | - | (16) Moramide-intermediate, 2-methyl-3-morpholino-1, |
---|
964 | | - | 1-diphenylpropane-carboxylic acid...............................9802 |
---|
965 | | - | (17) Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] |
---|
966 | | - | ({2-[(9 R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9- |
---|
967 | | - | yl]ethyl})amine fumarate).............................................9245 |
---|
968 | | - | (18) Pethidine (meperidine)..................................................9230 |
---|
969 | | - | (19) Pethidine-intermediate-A, 4-cyano-1-methyl-4- |
---|
970 | | - | phenylpiperidine............................................................9232 |
---|
971 | | - | (20) Pethidine-intermediate-B, ethyl-4-phenyl- |
---|
972 | | - | piperidine-4-carboxylate...............................................9233 |
---|
973 | | - | (21) Pethidine-intermediate-C, 1-methyl-4-phenyl-piperidine-4- |
---|
974 | | - | carboxylic acid..............................................................9234 |
---|
975 | | - | (22) Phenazocine..................................................................9715 |
---|
976 | | - | (23) Piminodine....................................................................9730 |
---|
977 | | - | (24) Racemethorphan............................................................9732 |
---|
978 | | - | (25) Racemorphan................................................................9733 |
---|
979 | | - | (26) Sufentanil......................................................................9740 |
---|
980 | | - | (27) Levo-alphacetyl methadol.............................................9648 |
---|
981 | | - | Some other names: levo-alpha-acetyl methadol, |
---|
982 | | - | levomethadyl acetate or LAAM. |
---|
983 | | - | (28) Remifentanil..................................................................9739 |
---|
984 | | - | (29) Tapentadol.....................................................................9780 |
---|
985 | | - | (30) Thiafentanil...................................................................9729 |
---|
986 | | - | (d) Any material, compound, mixture, or preparation which |
---|
987 | | - | contains any quantity of the following substances having a potential for |
---|
988 | | - | abuse associated with a stimulant effect on the central nervous system: |
---|
989 | | - | (1) Amphetamine, its salts, optical isomers and salts of its |
---|
990 | | - | optical isomers...............................................................1100 |
---|
991 | | - | (2) Phenmetrazine and its salts...........................................1631 |
---|
992 | | - | (3) Methamphetamine, including its salts, isomers and salts of |
---|
993 | | - | isomers..........................................................................1105 |
---|
994 | | - | (4) Methylphenidate............................................................1724 |
---|
995 | | - | (5) Lisdexamfetamine, its salts, isomers, and salts of its |
---|
996 | | - | isomers..........................................................................1205 |
---|
997 | | - | (e) Unless specifically excepted or unless listed in another |
---|
998 | | - | schedule, any material, compound, mixture or preparation which |
---|
999 | | - | contains any quantity of the following substances having a depressant |
---|
1000 | | - | effect on the central nervous system, including its salts, isomers and |
---|
1001 | | - | salts of isomers whenever the existence of such salts, isomers and salts |
---|
1002 | | - | of isomers is possible within the specific chemical designation: |
---|
1003 | | - | (1) Amobarbital..................................................................2125 |
---|
1004 | | - | (2) Glutethimide..................................................................2550 |
---|
1005 | | - | (3) Secobarbital...................................................................2315 |
---|
1006 | | - | (4) Pentobarbital.................................................................2270 |
---|
1007 | | - | (5) Phencyclidine................................................................7471 |
---|
1008 | | - | (f) Any material, compound, mixture, or preparation which |
---|
1009 | | - | contains any quantity of the following substances: |
---|
1010 | | - | (1) Immediate precursor to amphetamine and HOUSE BILL No. 2547—page 18 |
---|
1011 | | - | methamphetamine: |
---|
1012 | | - | (A) Phenylacetone.........................................................8501 |
---|
1013 | | - | Some trade or other names: phenyl-2-propanone; P2P; |
---|
1014 | | - | benzyl methyl ketone; methyl benzyl ketone. |
---|
1015 | | - | (2) Immediate precursors to phencyclidine (PCP): |
---|
1016 | | - | (A) 1-phenylcyclohexylamine.......................................7460 |
---|
1017 | | - | (B) 1-piperidinocyclohexanecarbonitrile (PCC)...........8603 |
---|
1018 | | - | (3) Immediate precursor to fentanyl: |
---|
1019 | | - | (A) 4-anilino-N-phenethylpiperidine |
---|
1020 | | - | (ANPP)..........................................................................8333 |
---|
1021 | | - | (B) N-phenyl-N-(piperidin- |
---|
1022 | | - | 4-yl)propionamide (norfentanyl)...................................8366 |
---|
1023 | | - | (g) Any material, compound, mixture or preparation which |
---|
1024 | | - | contains any quantity of the following hallucinogenic substance, its |
---|
1025 | | - | salts, isomers and salts of isomers, unless specifically excepted, |
---|
1026 | | - | whenever the existence of these salts, isomers and salts of isomers is |
---|
1027 | | - | possible within the specific chemical designation: |
---|
1028 | | - | (1) Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an |
---|
1029 | | - | oral solution in a drug product approved for marketing by |
---|
1030 | | - | the United States food and drug administration............7365 |
---|
1031 | | - | (2) Nabilone........................................................................7379 |
---|
1032 | | - | [Another name for nabilone: (±)-trans-3-(1,1- |
---|
1033 | | - | dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy- |
---|
1034 | | - | 6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one] |
---|
1035 | | - | (h) Any material, compound, mixture or preparation containing |
---|
1036 | | - | any of the following narcotic drugs or any salts calculated as the free |
---|
1037 | | - | anhydrous base or alkaloid, in limited quantities as set forth below: |
---|
1038 | | - | (1) Not more than 300 milligrams of dihydrocodeinone |
---|
1039 | | - | (hydrocodone) or any of its salts per 100 milliliters or |
---|
1040 | | - | not more than 15 milligrams per dosage unit with a |
---|
1041 | | - | fourfold or greater quantity of an isoquinoline alkaloid |
---|
1042 | | - | of opium........................................................................9805 |
---|
1043 | | - | (2) Not more than 300 milligrams of dihydrocodeinone |
---|
1044 | | - | (hydrocodone) or any of its salts per 100 milliliters or not |
---|
1045 | | - | more than 15 milligrams per dosage unit with one or more |
---|
1046 | | - | active, nonnarcotic ingredients in recognized therapeutic |
---|
1047 | | - | amounts.........................................................................9806 |
---|
1048 | | - | Sec. 6. K.S.A. 2023 Supp. 65-4111 is hereby amended to read as |
---|
1049 | | - | follows: 65-4111. (a) The controlled substances listed in this section are |
---|
1050 | | - | included in schedule IV and the number set forth opposite each drug or |
---|
1051 | | - | substance is the DEA controlled substances code that has been assigned |
---|
1052 | | - | to it. |
---|
1053 | | - | (b) Any material, compound, mixture or preparation that contains |
---|
1054 | | - | any quantity of the following substances including its salts, isomers and |
---|
1055 | | - | salts of isomers whenever the existence of such salts, isomers and salts |
---|
1056 | | - | of isomers is possible within the specific chemical designation and |
---|
1057 | | - | having a potential for abuse associated with a depressant effect on the |
---|
1058 | | - | central nervous system: |
---|
1059 | | - | (1) Alprazolam....................................................................2882 |
---|
1060 | | - | (2) Barbital..........................................................................2145 |
---|
1061 | | - | (3) Brexanolone..................................................................2400 |
---|
1062 | | - | (4) Bromazepam ................................................................2748 |
---|
1063 | | - | (5) Camazepam...................................................................2749 |
---|
1064 | | - | (6) Carisoprodol..................................................................8192 |
---|
1065 | | - | (7) Chloral betaine..............................................................2460 |
---|
1066 | | - | (8) Chloral hydrate..............................................................2465 |
---|
1067 | | - | (9) Chlordiazepoxide..........................................................2744 |
---|
1068 | | - | (10) Clobazam......................................................................2751 |
---|
1069 | | - | (11) Clonazepam...................................................................2737 HOUSE BILL No. 2547—page 19 |
---|
1070 | | - | (12) Clorazepate....................................................................2768 |
---|
1071 | | - | (13) Clotiazepam..................................................................2752 |
---|
1072 | | - | (14) Cloxazolam...................................................................2753 |
---|
1073 | | - | (15) Daridorexant.................................................................2410 |
---|
1074 | | - | (16) Delorazepam.................................................................2754 |
---|
1075 | | - | (16)(17) Diazepam......................................................................2765 |
---|
1076 | | - | (17)(18) Dichloralphenazone......................................................2467 |
---|
1077 | | - | (18)(19) Estazolam......................................................................2756 |
---|
1078 | | - | (19)(20) Ethchlorvynol................................................................2540 |
---|
1079 | | - | (20)(21) Ethinamate....................................................................2545 |
---|
1080 | | - | (21)(22) Ethyl loflazepate...........................................................2758 |
---|
1081 | | - | (22)(23) Fludiazepam..................................................................2759 |
---|
1082 | | - | (23)(24) Flunitrazepam................................................................2763 |
---|
1083 | | - | (24)(25) Flurazepam....................................................................2767 |
---|
1084 | | - | (25)(26) Fospropofol...................................................................2138 |
---|
1085 | | - | (26)(27) Halazepam.....................................................................2762 |
---|
1086 | | - | (27)(28) Haloxazolam................................................................2771 |
---|
1087 | | - | (28)(29) Ketazolam.....................................................................2772 |
---|
1088 | | - | (29)(30) Lemborexant.................................................................2245 |
---|
1089 | | - | (30)(31)Loprazolam...................................................................2773 |
---|
1090 | | - | (31)(32)Lorazepam.....................................................................2885 |
---|
1091 | | - | (32)(33) Lormetazepam...............................................................2774 |
---|
1092 | | - | (33)(34) Mebutamate...................................................................2800 |
---|
1093 | | - | (34)(35) Medazepam...................................................................2836 |
---|
1094 | | - | (35)(36) Meprobamate................................................................2820 |
---|
1095 | | - | (36)(37) Methohexital.................................................................2264 |
---|
1096 | | - | (37)(38) Methylphenobarbital (mephobarbital)..........................2250 |
---|
1097 | | - | (38)(39) Midazolam....................................................................2884 |
---|
1098 | | - | (39)(40) Nimetazepam................................................................2837 |
---|
1099 | | - | (40)(41) Nitrazepam....................................................................2834 |
---|
1100 | | - | (41)(42) Nordiazepam.................................................................2838 |
---|
1101 | | - | (42)(43) Oxazepam......................................................................2835 |
---|
1102 | | - | (43)(44) Oxazolam......................................................................2839 |
---|
1103 | | - | (44)(45) Paraldehyde...................................................................2585 |
---|
1104 | | - | (45)(46) Petrichloral....................................................................2591 |
---|
1105 | | - | (46)(47) Phenobarbital................................................................2285 |
---|
1106 | | - | (47)(48) Pinazepam.....................................................................2883 |
---|
1107 | | - | (48)(49) Prazepam.......................................................................2764 |
---|
1108 | | - | (49)(50) Quazepam......................................................................2881 |
---|
1109 | | - | (50)(51) Remimazolam...............................................................2846 |
---|
1110 | | - | (51)(52) Temazepam...................................................................2925 |
---|
1111 | | - | (52)(53) Tetrazepam....................................................................2886 |
---|
1112 | | - | (53)(54) Triazolam......................................................................2887 |
---|
1113 | | - | (54)(55) Zolpidem.......................................................................2783 |
---|
1114 | | - | (55)(56) Zaleplon........................................................................2781 |
---|
1115 | | - | (56)(57) Zopiclone......................................................................2784 |
---|
1116 | | - | (57) 2-[(dimethylamino)methyl]-1-(3- |
---|
1117 | | - | methoxyphenyl)cyclohexanol, its salts, optical and |
---|
1118 | | - | geometric isomers and salts of these isomers (including |
---|
1119 | | - | tramadol). ......................................................................9752 |
---|
1120 | | - | (58) Alfaxalone.....................................................................2731 |
---|
1121 | | - | (59) Suvorexant....................................................................2223 |
---|
1122 | | - | (c) Any material, compound, mixture, or preparation that contains |
---|
1123 | | - | any quantity of fenfluramine (1670), including its salts, isomers |
---|
1124 | | - | (whether optical, position or geometric) and salts of such isomers, |
---|
1125 | | - | whenever the existence of such salts, isomers and salts of isomers is |
---|
1126 | | - | possible. The provisions of this subsection (c) shall expire on the date |
---|
1127 | | - | fenfluramine and its salts and isomers are removed from schedule IV of |
---|
1128 | | - | the federal controlled substances act (21 U.S.C. § 812; 21 code of HOUSE BILL No. 2547—page 20 |
---|
1129 | | - | federal regulations 1308.14). |
---|
1130 | | - | (d) Any material, compound, mixture or preparation that contains |
---|
1131 | | - | any quantity of lorcaserin (1625), including its salts, isomers and salts |
---|
1132 | | - | of such isomers, whenever the existence of such salts, isomers and salts |
---|
1133 | | - | of isomers is possible (21 U.S.C. § 812; 21 code of federal regulations |
---|
1134 | | - | C.F.R. § 1308.14). |
---|
1135 | | - | (e)(d) Unless specifically excepted or unless listed in another |
---|
1136 | | - | schedule, any material, compound, mixture or preparation that contains |
---|
1137 | | - | any quantity of the following substances having a stimulant effect on |
---|
1138 | | - | the central nervous system, including its salts, isomers (whether optical, |
---|
1139 | | - | position or geometric) and salts of such isomers whenever the existence |
---|
1140 | | - | of such salts, isomers and salts of isomers is possible within the |
---|
1141 | | - | specific chemical designation: |
---|
1142 | | - | (1) Cathine ((+)-norpseudoephedrine)................................1230 |
---|
1143 | | - | (2) Diethylpropion..............................................................1610 |
---|
1144 | | - | (3) Fencamfamin.................................................................1760 |
---|
1145 | | - | (4) Fenproporex..................................................................1575 |
---|
1146 | | - | (5) Mazindol.......................................................................1605 |
---|
1147 | | - | (6) Mefenorex.....................................................................1580 |
---|
1148 | | - | (7) Pemoline (including organometallic |
---|
1149 | | - | complexes and chelates thereof)...................................1530 |
---|
1150 | | - | (8) Phentermine..................................................................1640 |
---|
1151 | | - | The provisions of this subsection (e)(8) (d)(8) shall expire on the |
---|
1152 | | - | date phentermine and its salts and isomers are removed from schedule |
---|
1153 | | - | IV of the federal controlled substances act (21 U.S.C. § 812; 21 code of |
---|
1154 | | - | federal regulations C.F.R. § 1308.14). |
---|
1155 | | - | (9) Pipradrol........................................................................1750 |
---|
1156 | | - | (10) Serdexmethylphenidate.................................................1729 |
---|
1157 | | - | (11) SPA((-)-1-dimethylamino-1, 2-diphenylethane)...........1635 |
---|
1158 | | - | (11)(12) Sibutramine...................................................................1675 |
---|
1159 | | - | (12)(13) Solriamfetol (2-amino-3-phenylpropyl carbamate; |
---|
1160 | | - | benzenepropanol, beta-amino-, carbamate (ester)).......1650 |
---|
1161 | | - | (13)(14) Mondafinil.....................................................................1680 |
---|
1162 | | - | (f)(e) Unless specifically excepted or unless listed in another |
---|
1163 | | - | schedule, any material, compound, mixture or preparation that contains |
---|
1164 | | - | any quantity of the following, including salts thereof: |
---|
1165 | | - | (1) Pentazocine...................................................................9709 |
---|
1166 | | - | (2) Butorphanol (including its optical isomers)..................9720 |
---|
1167 | | - | (3) Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6- |
---|
1168 | | - | dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H- |
---|
1169 | | - | imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic |
---|
1170 | | - | acid) (including its optical isomers) and its salts, isomers, |
---|
1171 | | - | and salts of isomers.......................................................9725 |
---|
1172 | | - | (g)(f) Unless specifically excepted or unless listed in another |
---|
1173 | | - | schedule, any material, compound, mixture or preparation containing |
---|
1174 | | - | any of the following narcotic drugs, or their salts calculated as the free |
---|
1175 | | - | anhydrous base or alkaloid, in limited quantities as set forth below: |
---|
1176 | | - | (1) Not more than 1 milligram of difenoxin and not less than |
---|
1177 | | - | 25 micrograms of atropine sulfate per dosage unit.......9167 |
---|
1178 | | - | (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2- |
---|
1179 | | - | diphenyl-3-methyl-2-propion-oxybutane)....................9278 |
---|
1180 | | - | (3) 2-[(dimethylamino)methyl]-1-(3- |
---|
1181 | | - | methoxyphenyl)cyclohexanol, its salts, optical and |
---|
1182 | | - | geometric isomers and salts of these isomers (including |
---|
1183 | | - | tramadol)......................................................................9752 |
---|
1184 | | - | (h)(g) Butyl nitrite and its salts, isomers, esters, ethers or their |
---|
1185 | | - | salts. |
---|
1186 | | - | (i)(h) The board may except by rule and regulation any compound, |
---|
1187 | | - | mixture or preparation containing any depressant substance listed in HOUSE BILL No. 2547—page 21 |
---|
1188 | | - | subsection (b) from the application of all or any part of this act if the |
---|
1189 | | - | compound, mixture or preparation contains one or more active |
---|
1190 | | - | medicinal ingredients not having a depressant effect on the central |
---|
1191 | | - | nervous system, and if the admixtures are included therein in |
---|
1192 | | - | combinations, quantity, proportion or concentration that vitiate the |
---|
1193 | | - | potential for abuse of the substances that have a depressant effect on |
---|
1194 | | - | the central nervous system. |
---|
1195 | | - | Sec. 7. K.S.A. 2023 Supp. 65-4113 is hereby amended to read as |
---|
1196 | | - | follows: 65-4113. (a) The controlled substances or drugs, by whatever |
---|
1197 | | - | official name, common or usual name, chemical name or brand name |
---|
1198 | | - | designated, listed in this section are included in schedule V. |
---|
1199 | | - | (b) Any compound, mixture or preparation containing limited |
---|
1200 | | - | quantities of any of the following narcotic drugs which also contains |
---|
1201 | | - | one or more nonnarcotic active medicinal ingredients in sufficient |
---|
1202 | | - | proportion to confer upon the compound, mixture or preparation |
---|
1203 | | - | valuable medicinal qualities other than those possessed by the narcotic |
---|
1204 | | - | drug alone: |
---|
1205 | | - | (1) Not more than 200 milligrams of codeine or any of its salts per |
---|
1206 | | - | 100 milliliters or per 100 grams. |
---|
1207 | | - | (2) Not more than 100 milligrams of dihydrocodeine or any of its |
---|
1208 | | - | salts per 100 milliliters or per 100 grams. |
---|
1209 | | - | (3) Not more than 100 milligrams of ethylmorphine or any of its |
---|
1210 | | - | salts per 100 milliliters or per 100 grams. |
---|
1211 | | - | (4) Not more than 2.5 milligrams of diphenoxylate and not less |
---|
1212 | | - | than 25 micrograms of atropine sulfate per dosage unit. |
---|
1213 | | - | (5) Not more than 100 milligrams of opium per 100 milliliters or |
---|
1214 | | - | per 100 grams. |
---|
1215 | | - | (6) Not more than .5 milligram of difenoxin (9168) and not less |
---|
1216 | | - | than 25 micrograms of atropine sulfate per dosage unit. |
---|
1217 | | - | (c) Unless specifically excepted or unless listed in another |
---|
1218 | | - | schedule, any material, compound, mixture or preparation which |
---|
1219 | | - | contains any quantity of the following substances having a stimulant |
---|
1220 | | - | effect on the central nervous system, including its salts, isomers |
---|
1221 | | - | (whether optical, position or geometric) and salts of such isomers |
---|
1222 | | - | whenever the existence of such salts, isomers and salts of isomers is |
---|
1223 | | - | possible within the specific chemical designation: |
---|
1224 | | - | (1) Propylhexedrine (except when part of a compound used for |
---|
1225 | | - | nasal decongestion which is authorized to be sold lawfully |
---|
1226 | | - | over the counter without a prescription under the federal |
---|
1227 | | - | food, drug and cosmetic act, so long as it is used only for |
---|
1228 | | - | such purpose)................................................................8161 |
---|
1229 | | - | (2) Pyrovalerone.................................................................1485 |
---|
1230 | | - | (d) Any compound, mixture or preparation containing any |
---|
1231 | | - | detectable quantity of ephedrine, its salts or optical isomers, or salts of |
---|
1232 | | - | optical isomers. |
---|
1233 | | - | (e) Any compound, mixture or preparation containing any |
---|
1234 | | - | detectable quantity of pseudoephedrine, its salts or optical isomers, or |
---|
1235 | | - | salts of optical isomers. |
---|
1236 | | - | (f) Unless specifically exempted or excluded or unless listed in |
---|
1237 | | - | another schedule, any material, compound, mixture, or preparation |
---|
1238 | | - | which contains any quantity of the following substances having a |
---|
1239 | | - | depressant effect on the central nervous system, including its salts: |
---|
1240 | | - | (1) Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] |
---|
1241 | | - | butanamide) (some trade or other names BRV; UCB- |
---|
1242 | | - | 34714; |
---|
1243 | | - | Briviact)........................................................................2710 |
---|
1244 | | - | (2) Cenobamate [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2- |
---|
1245 | | - | yl)ethyl] carbamate.......................................................2720 |
---|
1246 | | - | (3) Ezogabine N-[2-amino-4(4-fluorobenzylamino) HOUSE BILL No. 2547—page 22 |
---|
1247 | | - | -phenyl]-carbamic acid ethyl ester................................2779 |
---|
1248 | | - | (4) Ganaxolone...................................................................2401 |
---|
1249 | | - | (5) Lacosamide [(R)-2-acetoamido-N-benzyl-3 |
---|
1250 | | - | -methoxy-propionamide]..............................................2746 |
---|
1251 | | - | (5)(6) Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4- |
---|
1252 | | - | carbonyl)pyridine-2-yl-benzamide................................2790 |
---|
1253 | | - | (6)(7)Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid].....2782 |
---|
1254 | | - | Sec. 8. K.S.A. 72-6283 is hereby amended to read as follows: 72- |
---|
| 102 | + | (d) The terms used in this section mean the same as defined in K.S.A. |
---|
| 103 | + | 72-6283, and amendments thereto. |
---|
| 104 | + | Sec. 3. K.S.A. 72-6283 is hereby amended to read as follows: 72- |
---|